Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D

Richard Mittleman, Arthur Chausmer, Josephine Bellavia, Stanley Wallach

Research output: Contribution to journalArticle

Abstract

To investigate the relation between the hypocalcemic activity of thyrocalci-tonin and the rate of bone resorption, the quantitative effect of exogenous thyrocalcitonin was studied in rats in which the rate of bone resorption was altered by thyroparathyroidectomy and by the administi’ation of calcium salts, parathyroid extract or vitamin D3. In sham-operated rats made hypercalcemic by the oral administration of CaCl2, thyrocalcitonin had no significant hypocalcemic activity. In thyroparathyroidec-tomized rats given oral CaCl2, a full Hypocalcemic response to thyrocalcitonin, of 1.49 mEq/I, occurred. In sham-operated and thyropara thyroid-ectomized rats made hypercalcemic by the administration of parathyroid extract, thyrocalcitonin caused mean decreases in the plasma concentration of calcium of 0.83 and 1.47 mEq/I, respectively. In hypercalcemia produced by the administration of a single dose of 105USP U of vitamin D3, sham-operated and thyroparathyroidectomized rats showed mean decreases in the plasma concentration of calcium of 1.32 and 1.24 mEq/I, respectively, during thyrocalcitonin administration. A similar hypocalcemic response was seen in thyroparathyroidectomized rats given a 10-fold greater dose of vitamin D3. In collateral studies of the release of 86Sr from the skeleton, thyroparathyroidectomy decreased, and vitamin D3administration markedly increased, the ratio of urinary85Sr to tibial85Sr. The administration of thyrocalcitonin produced decreases in the excretion of85Sr which were parallel to the control values for the ratio of urinary85Sr to tibial85Sr. These data indicate that the degree to which thyrocalcitonin can inhibit bone resorption is dependent upon the prevailing rate of bone resorption. This characteristic of thyrocalcitonin action may be significant in the treatment of human hypercalcemia with thyrocalcitonin.

Original languageEnglish (US)
Pages (from-to)566-604
Number of pages39
JournalEndocrinology
Volume81
Issue number3
DOIs
StatePublished - 1967
Externally publishedYes

Fingerprint

Calcitonin
Hypercalcemia
Parathyroid Hormone
Vitamin D
Salts
Calcium
Bone Resorption
Cholecalciferol
Skeleton
Vitamins
Oral Administration
Thyroid Gland

ASJC Scopus subject areas

  • Endocrinology

Cite this

Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D. / Mittleman, Richard; Chausmer, Arthur; Bellavia, Josephine; Wallach, Stanley.

In: Endocrinology, Vol. 81, No. 3, 1967, p. 566-604.

Research output: Contribution to journalArticle

Mittleman, Richard ; Chausmer, Arthur ; Bellavia, Josephine ; Wallach, Stanley. / Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D. In: Endocrinology. 1967 ; Vol. 81, No. 3. pp. 566-604.
@article{4149e7f69ea44055bc106c13591bac40,
title = "Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D",
abstract = "To investigate the relation between the hypocalcemic activity of thyrocalci-tonin and the rate of bone resorption, the quantitative effect of exogenous thyrocalcitonin was studied in rats in which the rate of bone resorption was altered by thyroparathyroidectomy and by the administi’ation of calcium salts, parathyroid extract or vitamin D3. In sham-operated rats made hypercalcemic by the oral administration of CaCl2, thyrocalcitonin had no significant hypocalcemic activity. In thyroparathyroidec-tomized rats given oral CaCl2, a full Hypocalcemic response to thyrocalcitonin, of 1.49 mEq/I, occurred. In sham-operated and thyropara thyroid-ectomized rats made hypercalcemic by the administration of parathyroid extract, thyrocalcitonin caused mean decreases in the plasma concentration of calcium of 0.83 and 1.47 mEq/I, respectively. In hypercalcemia produced by the administration of a single dose of 105USP U of vitamin D3, sham-operated and thyroparathyroidectomized rats showed mean decreases in the plasma concentration of calcium of 1.32 and 1.24 mEq/I, respectively, during thyrocalcitonin administration. A similar hypocalcemic response was seen in thyroparathyroidectomized rats given a 10-fold greater dose of vitamin D3. In collateral studies of the release of 86Sr from the skeleton, thyroparathyroidectomy decreased, and vitamin D3administration markedly increased, the ratio of urinary85Sr to tibial85Sr. The administration of thyrocalcitonin produced decreases in the excretion of85Sr which were parallel to the control values for the ratio of urinary85Sr to tibial85Sr. These data indicate that the degree to which thyrocalcitonin can inhibit bone resorption is dependent upon the prevailing rate of bone resorption. This characteristic of thyrocalcitonin action may be significant in the treatment of human hypercalcemia with thyrocalcitonin.",
author = "Richard Mittleman and Arthur Chausmer and Josephine Bellavia and Stanley Wallach",
year = "1967",
doi = "10.1210/endo-81-3-599",
language = "English (US)",
volume = "81",
pages = "566--604",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Thyrocalcitonin activity in hypercalcemia produced by calcium salts, parathyroid hormone and vitamin D

AU - Mittleman, Richard

AU - Chausmer, Arthur

AU - Bellavia, Josephine

AU - Wallach, Stanley

PY - 1967

Y1 - 1967

N2 - To investigate the relation between the hypocalcemic activity of thyrocalci-tonin and the rate of bone resorption, the quantitative effect of exogenous thyrocalcitonin was studied in rats in which the rate of bone resorption was altered by thyroparathyroidectomy and by the administi’ation of calcium salts, parathyroid extract or vitamin D3. In sham-operated rats made hypercalcemic by the oral administration of CaCl2, thyrocalcitonin had no significant hypocalcemic activity. In thyroparathyroidec-tomized rats given oral CaCl2, a full Hypocalcemic response to thyrocalcitonin, of 1.49 mEq/I, occurred. In sham-operated and thyropara thyroid-ectomized rats made hypercalcemic by the administration of parathyroid extract, thyrocalcitonin caused mean decreases in the plasma concentration of calcium of 0.83 and 1.47 mEq/I, respectively. In hypercalcemia produced by the administration of a single dose of 105USP U of vitamin D3, sham-operated and thyroparathyroidectomized rats showed mean decreases in the plasma concentration of calcium of 1.32 and 1.24 mEq/I, respectively, during thyrocalcitonin administration. A similar hypocalcemic response was seen in thyroparathyroidectomized rats given a 10-fold greater dose of vitamin D3. In collateral studies of the release of 86Sr from the skeleton, thyroparathyroidectomy decreased, and vitamin D3administration markedly increased, the ratio of urinary85Sr to tibial85Sr. The administration of thyrocalcitonin produced decreases in the excretion of85Sr which were parallel to the control values for the ratio of urinary85Sr to tibial85Sr. These data indicate that the degree to which thyrocalcitonin can inhibit bone resorption is dependent upon the prevailing rate of bone resorption. This characteristic of thyrocalcitonin action may be significant in the treatment of human hypercalcemia with thyrocalcitonin.

AB - To investigate the relation between the hypocalcemic activity of thyrocalci-tonin and the rate of bone resorption, the quantitative effect of exogenous thyrocalcitonin was studied in rats in which the rate of bone resorption was altered by thyroparathyroidectomy and by the administi’ation of calcium salts, parathyroid extract or vitamin D3. In sham-operated rats made hypercalcemic by the oral administration of CaCl2, thyrocalcitonin had no significant hypocalcemic activity. In thyroparathyroidec-tomized rats given oral CaCl2, a full Hypocalcemic response to thyrocalcitonin, of 1.49 mEq/I, occurred. In sham-operated and thyropara thyroid-ectomized rats made hypercalcemic by the administration of parathyroid extract, thyrocalcitonin caused mean decreases in the plasma concentration of calcium of 0.83 and 1.47 mEq/I, respectively. In hypercalcemia produced by the administration of a single dose of 105USP U of vitamin D3, sham-operated and thyroparathyroidectomized rats showed mean decreases in the plasma concentration of calcium of 1.32 and 1.24 mEq/I, respectively, during thyrocalcitonin administration. A similar hypocalcemic response was seen in thyroparathyroidectomized rats given a 10-fold greater dose of vitamin D3. In collateral studies of the release of 86Sr from the skeleton, thyroparathyroidectomy decreased, and vitamin D3administration markedly increased, the ratio of urinary85Sr to tibial85Sr. The administration of thyrocalcitonin produced decreases in the excretion of85Sr which were parallel to the control values for the ratio of urinary85Sr to tibial85Sr. These data indicate that the degree to which thyrocalcitonin can inhibit bone resorption is dependent upon the prevailing rate of bone resorption. This characteristic of thyrocalcitonin action may be significant in the treatment of human hypercalcemia with thyrocalcitonin.

UR - http://www.scopus.com/inward/record.url?scp=85003167558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003167558&partnerID=8YFLogxK

U2 - 10.1210/endo-81-3-599

DO - 10.1210/endo-81-3-599

M3 - Article

VL - 81

SP - 566

EP - 604

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -